Key result
Antiarrhythmic medication remains important adjunctive therapy alongside ICD and ablation for electrical storm.
Why the study?
What is the optimal antiarrhythmic drug therapy for patients with electrical storm?
What is the optimal antiarrhythmic drug therapy for patients with electrical storm?
Antiarrhythmic medication remains an important adjunctive therapy for patients experiencing electrical storm.
Answers are grounded in this paper and cite their sources.
Reinforces adjunctive antiarrhythmics in electrical storm; leaves open optimal agent selection.
Electrical storm, defined as 3 or more separate episodes of ventricular tachycardia or ventricular fibrillation within 24 hours, carries significant morbidity and mortality. These unstable ventricular arrhythmias have been described with a variety of conditions including ischemic heart disease, structural heart disease, and genetic conditions. While implantable cardioverter defibrillator implantation and ablation may be indicated and required, antiarrhythmic medication remains an important adjunctive therapy for these persons.
No takes yet. Share an insight, caveat, or question.
Sorajja et al. (2015) conducted a review in Electrical storm. Antiarrhythmic drug therapy was evaluated. Antiarrhythmic medication remains an important adjunctive therapy for patients experiencing electrical storm, alongside ICD implantation and ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: